ThursdayAug 19, 2021 11:52 am

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) Is ‘One to Watch’

Delic is led by a best-in-class team of industry veterans with over 100 years of working knowledge in cannabis, finance, and psychedelic research The Vancouver-based company was formed in 2019 as the ‎first psychedelic umbrella platform The Delic self-sustaining Ecosystem covers three main areas: media, health, and science On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company, a legacy counterculture distributor of psychedelic media An estimated $238 billion is spent annually in the U.S. on mental health treatments and ancillary services University-led and FDA-approved studies are positioning North America as a leading region in the advancement…

Continue Reading

TuesdayAug 17, 2021 12:40 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) Announces Keynote Speaker for Upcoming Psychedelic and Wellness Event – Meet Delic

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced that Laura Dawn, Msc. will serve as one of the headlining speakers at Meet Delic on Nov. 6, 2021. According to the update, her keynote, “Exploring the Intersection Between Psychedelics & Creative Problem Solving,” targets business and thought-leaders, entrepreneurs and creators. “Laura Dawn is well-known among the business leaders and entrepreneurial circuits for helping share the benefits of psychedelics in personal and professional development and is exactly the voice we look to highlight at Meet Delic,” said Meet Delic co-founder and executive producer Jackee Stang. “Her coaching,…

Continue Reading

TuesdayAug 10, 2021 9:00 am

QualityStocksNewsBreaks – Delic Corp Inc. (CSE: DELC) (OTCQB: DELCF) Scientific Advisor Granted Full Professorship

Delic Corp Inc. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has announced that Glenn Sammis, a professor and scientific advisor to subsidiary Delic Labs, has received a full professorship at the University of British Columbia in the chemistry department. The announcement also noted that Sammis will be working closely with Dr. Markus Roggen in developing intellectual property (“IP”) for Delic Labs' cannabis and psilocybin research; he will take a yearlong sabbatical from his position at the university to pursue this research. A federally authorized psilocybin and cannabis research laboratory, Delic Labs is focused on extraction, analytical testing and chemical process development. The facility conducts research…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered